hepatitis or tumor News

The Board of Directors of the Caring for Carcinoid Foundation is pleased to announce the appointment of Ron Hollander as its new Executive Director.

New Trends in Preventive and Therapeutic Vaccines: R&D Activities and Commercial Prospects

Two pre-eminent organizations fighting to eliminate cancer in dogs, strive to do it together! Chase Away K9 Cancer will now direct their fundraising efforts towards research grants approved through the National Canine Cancer Foundation.

Collaboration with the Stanley lab shows that there are natural compounds from plants that can control this deadly disorder and, with the atomic structure in hand, can be used as a starting point for further drug design.

In the world, 500 million people are living with Hepatitis B or C. And only a small percentage of them are aware of this fact.

Steven Olson of the University of Illinois at Chicago College of Dentistry has received a $3.12 million federal grant for research on anticoagulant proteins that regulate blood clotting and prevent abnormal clotting.

The Board of Directors of the Caring for Carcinoid Foundation is pleased to announce the appointment of Ron Hollander as its new Executive Director.

Scientists from MIT, Rockefeller University and the Medical College of Wisconsin have found a technique to generate liver-like cells made from stem cells.

A new national helpline, 877-HELP-4-HEP, run by and for people affected by hepatitis C will formally launch February 1, 2012.

Merck Pharmaceuticals announced that it was planning on “making whatever deals are necessary” to make sure the company maintains its lead in developing and manufacturing oral medications to treat the Hepatitis C virus.

The Center for the Biology of Chronic Disease (CBCD) has recently learned that Bristol-Myers Squibb Co. will lose patent protection for three of its top four drugs within the next three years.

A paper published ahead of print in the Journal of Infectious Diseases says that Chronic Hepatitis B virus (HBV) infection almost doubles the risk of AIDS or death in people diagnosed with HIV infection.

NIH Sponsored Investigator Dr. David Kingston from Virginia Tech Gains Access to the Formerly Private Merck Natural Products Collection

A committee convened by the National Academy of Sciences has released a report establishing the first set of criteria for research on chimpanzees.

Bristol-Myers Squibb is now collaborating on the development of a new Hepatitis C therapy with Tibotec Pharmaceuticals.

The Center for the Biology of Chronic Disease (CBCD) applauds Danish insulin giant, Novo Nordisk’s decision to stop using live animals in biological product control tests.

Over two million people in India die due to chronic liver disease. Of them, 15% are infected with the Hepatitis C virus (HCV) while 45 % die due to the Hepatitis B virus (HBV).

German researchers believe a substance found in green tea may offer an antiviral strategy to prevent Hepatitis C “reinfection."

The Center for the Biology of Chronic Disease (CBCD) has learned that there is a shortage of Hepatitis B (HBV) vaccine in Nagpur city, India.

Apparently the Hepatitis C drug Incivek manufactured by pharmaceutical company, Vertex and Victrelis, a competing HCV drug which is manufactured by Merk & Co., Inc. are no longer just fighting each other for marketplace dominance.

Vertex Pharmaceuticals’ new drug, “Incivek” has beaten Merck’s “Victrelis’s” sales by a gigantic margin.

The Caring for Carcinoid Foundation (CFCF) is pleased to announce its celebratory programming in honor of Worldwide NET Cancer Awareness Day. CFCF-sponsored events include a Patient Education Seminar and awarding grants to patient support groups.

New Trends in Preventive and Therapeutic Vaccines: R&D Activities and Commercial Prospects

Bristol-Myers Squibb Co.'s new drug called BMS-790052 in combination with peginterferon and ribavirin cured up to 83% of patients infected with Hepatitis C.

polyDNA, the makers of Gene-Eden-Blue congratulates Pharmasset, Inc. on the success of a new study described as a “home run” in the fight against viral Hepatitis C.

Gene-Eden Blue is First Antiviral, All Natural Remedy Against Latent HCV with Extremely Reasonable Price.

polyDNA, Makers of Gene-Eden Blue, Joins FAIR in Urging HIV Advocates and Researchers to Consider Focusing on Battling Two of the Greatest Killers of HIV/AIDS Patients: Viral Hepatitis and Diabetes.

Two pre-eminent organizations fighting to eliminate cancer in dogs, strive to do it together! Chase Away K9 Cancer will now direct their fundraising efforts towards research grants approved through the National Canine Cancer Foundation.

According to an article authored by Ravi Jhaveri, MD and published through Medscape, symptoms for Hepatitis B (HBV) are seen in about 30% of children who are infected with the virus.

Collaboration with the Stanley lab shows that there are natural compounds from plants that can control this deadly disorder and, with the atomic structure in hand, can be used as a starting point for further drug design.

Only a third of those infected with Hepatitis B (HBV) actually know it. It is estimated that as many as 2,000,000 people are infected in the U.S. alone.

In the world, 500 million people are living with Hepatitis B or C. And only a small percentage of them are aware of this fact.

Steven Olson of the University of Illinois at Chicago College of Dentistry has received a $3.12 million federal grant for research on anticoagulant proteins that regulate blood clotting and prevent abnormal clotting.

A comprehensive portal for people living with hepatitis and their care providers

Bpogen is the latest product developed from bio-technically developed spirulina. An adequate usage of FEBICO Bpogen capsules, is the solution to building up strength, reducing fatigue, and good circulation.

New Healthcare market report from Datamonitor: "R&D Trends: Hepatitis C"

New Medical Devices research report from GlobalData is now available from Fast Market Research

ORGENTEC has developed a new lab test for diagnosing autoimmune liver diseases. The immunoblot is suitable for initial and differential diagnosis in cases of ambiguous symptoms or for differentiation of a positive result from screening tests.

Now a day, swimming in beaches and pools are the best thing to do because summer heat is going on. But, be alert because a sun ray produces ultra violet that might be harmful to our skin.

Simple blood test offer for women to improved an ovarian cancer survival rates. Simple blood test is to be made available to family doctors, according to the new health guidelines in the UK, and these can be saved a thousand of lives from...

Omega-3 is widely available in cold-water oily fish such as anchovies, herring, mackerel, sardines, and salmon. There is a newly discovered marine source of omega-3 fatty acids it is Krill oil.

Surgeon to Remove Potentially Deadly Tumor near Brainstem

Head, lung and neck cancer are able to identify by the new “electronic nose” which found the chemical signals of cancer in the patient breath.

The US researchers at The University of Massachusetts, Amherst, have conduct a study that revealed about the breast milk can help to detect of breast cancer.

Many new cancer weapons come as personalized therapies that can target specific changes in an individual’s tumor. Leading the work are Binghamton University researchers who are using a new tool in studying tubulin tyrosine ligase, or TTL enzyme.

A few years ago, my husband and I wanted to know about alternative cancer treatments really. We wanted to hear from people who used alternative therapy...

Dihydro-testosterone, is essential to develop prostate cancer, but not the actual cause of prostate cancer. Males are castrated at a young age do not develop prostate cancer.

April 13, 2011 the New York news about the new study of reasonable option for a treating the prostate cancer is needs to have evidence that closely watching the tumor for older men with low risk prostate cancer.

Pancreatic Cancer is a malignant neoplasm of the pancreas. The prognosis for the pancreatic cancer is still poor and the remission of this disease is still rare.

The National Cancer Institute (NCI) was awarded a $1.7 million to Fatih Uckun, MD, PhD, a research professor of Pediatrics at the Keck School of Medicine of the University of Southern California...

New Pharmaceuticals market report from Datamonitor: "Epidemiology: Hepatitis B in China"

Cases of AIDS-related cancers declined among people living with HIV in the United States, but other cancers are in March in this group has a new study.

Third Rock Ventures, the funding for cancer research with the transfer of more than $ 40 million Blueprint Pharmaceuticals...

Fast Market Research recommends "Hepatitis A Preventive Vaccines - Pipeline Assessment and Market Forecasts to 2017" from GlobalData, now available

In western Europe, a German researchers analyzed a data that found out about 50,400 out of a total 79,100 cases of certain types of cancer (such as tumours in throat and bowel) and this data gather from The Netherlands....

Cancer is the most leading researchable topic, because the main cause and treatment of the disease is still unknown.